The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Pathophysiologically based treatment interventions in schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Baddeley, A. (1992) · Science · doi:10.1126/science.1736359 · Cited by 5,258
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Self-citationSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Modulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593 · cited 1×
“and regulate the critical patterns of sustained neuronal firing in the DLPFC during working memory task”
BackgroundCognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Self-citationAkbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938
Self-citationMirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882
Self-citationStraub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341750 · Cited by 856
Cognitive Impairment in Schizophrenia Is the Core of the Disorder
Elvevag, B., & Goldberg, T. E. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.10 · Cited by 835 · cited 1×
“Working memory impairment: a core feature of schizophrenia Of the multiple clinical signs and symptoms of schizophrenia ( Box 1 ), impairments in cognition are now considered to be the core features of the disorde”
BackgroundGamma Oscillations Correlate with Working Memory Load in Humans
Howard, M. W. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg084 · Cited by 766
Prefrontal Dopamine D1Receptors and Working Memory in Schizophrenia
Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., Hwang, D.-R., Keilp, J., Kochan, L., Van Heertum, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03708.2002 · Cited by 724
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., et al. (1997) · Nature · doi:10.1038/385634a0 · Cited by 710
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697
Self-citationComplexity of Prefrontal Cortical Dysfunction in Schizophrenia: More Than Up or Down
Callicott, J. H., Mattay, V. S., Verchinski, B. A., Marenco, S., Egan, M. F., & Weinberger, D. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2209 · Cited by 673
Sawaguchi, T., & Goldman-Rakic, P. S. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.71.2.515 · Cited by 649
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648 · cited 1×
“The protein coded by the disrupted-in-schizophrenia 1 ( DISC1 ) gene sequesters the cAMP-degrading enzyme phosphodiesterase 4B and thus might regulate intracellular cAMP level”
BackgroundNeural synchrony indexes disordered perception and cognition in schizophrenia
Spencer, K. M., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M., Shenton, M. E., & McCarley, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406074101 · Cited by 597
Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia
Hahn, C.-G., Wang, H.-Y., Cho, D.-S., Talbot, K., Gur, R. E., Berrettini, W. H., Bakshi, K., Kamins, J., Borgmann-Winter, K. E., Siegel, S. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1418 · Cited by 563
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544
Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.023 · Cited by 520
Interneuron Diversity series: Inhibitory interneurons and network oscillations in vitro
Whittington, M. A., & Traub, R. D. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.09.016 · Cited by 501
Gulyás, A. I., Megı́as, M., Emri, Z., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-22-10082.1999 · Cited by 476
Abnormal Excitatory Neurotransmitter Metabolism in Schizophrenic Brains
Tsai, G. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950220039008 · Cited by 455
Verma, A., & Moghaddam, B. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00373.1996 · Cited by 449
Akbarian, S., Sucher, N., Bradley, D., Tafazzoli, A., Trinh, D., Hetrick, W., Potkin, S., Sandman, C., Bunney, W., & Jones, E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00019.1996 · Cited by 441
Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1
Flames, N., Long, J. E., Garratt, A. N., Fischer, T. M., Gassmann, M., Birchmeier, C., Lai, C., Rubenstein, J. L. R., & Marı́n, O. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.028 · Cited by 431
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains
Torrey, E. F., Barci, B. M., Webster, M. J., Bartko, J. J., Meador-Woodruff, J. H., & Knable, M. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.019 · Cited by 426
Tunbridge, E. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1124-04.2004 · Cited by 418
Woo, T.-U. W., Walsh, J. P., & Benes, F. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.649 · Cited by 411
A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia
Woo, T.-U., Whitehead, R. E., Melchitzky, D. S., & Lewis, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5341 · Cited by 410
Self-citationRao, S. G., Williams, G. V., & Goldman-Rakic, P. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00485.2000 · Cited by 407
Bringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403
Law, A. J., Lipska, B. K., Weickert, C. S., Hyde, T. M., Straub, R. E., Hashimoto, R., Harrison, P. J., Kleinman, J. E., & Weinberger, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602002103 · Cited by 402
Akil, M., Pierri, J. N., Whitehead, R. E., Edgar, C. L., Mohila, C., Sampson, A. R., & Lewis, D. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1580 · Cited by 393
Self-citationDefining a cognitive function decrement in schizophrenia
Keefe, R. S. E., Eesley, C. E., & Poe, M. P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.003 · Cited by 389
Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
Corfas, G., Roy, K., & Buxbaum, J. D. (2004) · Nature Neuroscience · doi:10.1038/nn1258 · Cited by 388
Akbarian, S., & Huang, H.-S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.001 · Cited by 363
Cognitive deficits as treatment targets in schizophrenia
Gold, J. M. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.008 · Cited by 354
Lewis, D. A., Melchitzky, D. S., Sesack, S. R., Whitehead, R. E., Auh, S., & Sampson, A. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1092 · Cited by 352
Self-citationWeickert, C. S., Straub, R. E., McClintock, B. W., Matsumoto, M., Hashimoto, R., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.544 · Cited by 352
Adler, C. M., Malhotra, A. K., Elman, I., Goldberg, T., Egan, M., Pickar, D., & Breier, A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1646 · Cited by 337
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
Konradi, C., & Heckers, S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336
Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329
Impact of complex genetic variation in COMT on human brain function
Meyer-Lindenberg, A., Nichols, T., Callicott, J. H., Ding, J., Kolachana, B., Buckholtz, J., Mattay, V. S., Egan, M., & Weinberger, D. R. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001860 · Cited by 319
MacDonald, A. W., Carter, C. S., Kerns, J. G., Ursu, S., Barch, D. M., Holmes, A. J., Stenger, V. A., & Cohen, J. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.475 · Cited by 318
Cure therapeutics and strategic prevention: raising the bar for mental health research
Insel, T. R., & Scolnick, E. M. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001777 · Cited by 313
Goldman-Rakic, P., Lidow, M., & Gallager, D. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02125.1990 · Cited by 312
Barch, D. M., Sheline, Y. I., Csernansky, J. G., & Snyder, A. Z. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01674-8 · Cited by 290
What Are the Right Targets for Psychopharmacology?
Hyman, S. E., & Fenton, W. S. (2003) · Science · doi:10.1126/science.1077141 · Cited by 283
Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia
Abi-Dargham, A., & Moore, H. (2003) · The Neuroscientist · doi:10.1177/1073858403252674 · Cited by 277
Volk, D. W. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.10.1063 · Cited by 265
Lewis, D., Volk, D., & Hashimoto, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1673-x · Cited by 253
Self-citationSelective prefrontal cortex inputs to dopamine cells: implications for schizophrenia
SESACK, S., & CARR, D. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00931-9 · Cited by 238
Cochran, S. M., Kennedy, M., McKerchar, C. E., Steward, L. J., Pratt, J. A., & Morris, B. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300031 · Cited by 236
Coyle, J., & Tsai, G. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1709-2 · Cited by 230
Cortical Development and Thalamic Pathology in Schizophrenia
Jones, E. G. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.3.483 · Cited by 223
Association of the NRG1 gene and schizophrenia: a meta-analysis
Munafò, M. R., Thiselton, D. L., Clark, T. G., & Flint, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001817 · Cited by 221
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.256 · Cited by 221
Self-citationKristiansen, L. V., Beneyto, M., Haroutunian, V, & Meador-Woodruff, J. H. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001844 · Cited by 220
D1Receptor in Interneurons of Macaque Prefrontal Cortex: Distribution and Subcellular Localization
Muly, E. C., Szigeti, K., & Goldman-Rakic, P. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10553.1998 · Cited by 217
Addington, A. M., Gornick, M., Duckworth, J., Sporn, A., Gogtay, N., Bobb, A., Greenstein, D., Lenane, M., Gochman, P., Baker, N., et al. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001599 · Cited by 206
Lewis, D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00393-1 · Cited by 203
Self-citationKeilhoff, G., Becker, A., Grecksch, G., Wolf, G., & Bernstein, H.-G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.039 · Cited by 199
The Neurochemical Circuitry of Schizophrenia
Carlsson, A. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-931483 · Cited by 197
Cannon, T. D., Glahn, D. C., Kim, J., Van Erp, T. G. M., Karlsgodt, K., Cohen, M. S., Nuechterlein, K. H., Bava, S., & Shirinyan, D. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1071 · Cited by 196
The GABA-glutamate connection in schizophrenia: which is the proximate cause?
Coyle, J. T. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.034 · Cited by 191
Dracheva, S., Marras, S. A. E., Elhakem, S. L., Kramer, F. R., Davis, K. L., & Haroutunian, V. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1400 · Cited by 190
Cunningham, M. O., Hunt, J., Middleton, S., LeBeau, F. E. N., Gillies, M. G., Davies, C. H., Maycox, P. R., Whittington, M. A., & Racca, C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5054-05.2006 · Cited by 188
Zaitsev, A. V., Gonzalez-Burgos, G., Povysheva, N. V., Kröner, S., Lewis, D. A., & Krimer, L. S. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhh218 · Cited by 182
Self-citationAltered Prefrontal Dopaminergic Function in Chronic Recreational Ketamine Users
Narendran, R., Frankle, W. G., Keefe, R., Gil, R., Martinez, D., Slifstein, M., Kegeles, L. S., Talbot, P. S., Huang, Y., Hwang, D.-R., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.12.2352 · Cited by 171
Huntley, G., Vickers, J., Janssen, W., Brose, N., Heinemann, S., & Morrison, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-06-03603.1994 · Cited by 161
Tan, H.-Y., Choo, W.-C., Fones, C. S. L., & Chee, M. W. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1849 · Cited by 161
Hippocampal gamma‐frequency oscillations: from interneurones to pyramidal cells, and back
Mann, E. O., Radcliffe, C. A., & Paulsen, O. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.078758 · Cited by 150
Sesack, S. R., Hawrylak, V. A., Melchitzky, D. S., & Lewis, D. A. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.7.614 · Cited by 150
Self-citationCritical Appraisal of DNA Microarrays in Psychiatric Genomics
Mirnics, K., Levitt, P. R., & Lewis, D. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.003 · Cited by 140
Self-citationExpression of N-Methyl-D-Aspartate receptor subunit mRNAs in the human brain: Hippocampus and cortex
Scherzer, C. R., Landwehrmeyer, G. B., Kerner, J. A., Counihan, T. J., Kosinski, C. M., Standaert, D. G., Daggett, L. P., Veli�elebi, G., Penney, J. B., & Young, A. B. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980105)390:1<75::aid-cne7>3.0.co;2-n · Cited by 137
Kröner, S., Krimer, L. S., Lewis, D. A., & Barrionuevo, G. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl012 · Cited by 125
Self-citationAssociation Between the Neuregulin 1 Gene and Schizophrenia: A Systematic Review
Tosato, S., Dazzan, P., & Collier, D. A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi043 · Cited by 115
Sawaguchi, T., Matsumura, M., & Kubota, K. (1989) · Experimental Brain Research · doi:10.1007/bf00249897 · Cited by 109
Sawaguchi, T. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00270-x · Cited by 107
Beyond bistability: Biophysics and temporal dynamics of working memory
Durstewitz, D., & Seamans, J. K. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.094 · Cited by 95
Tsukada, H., Nishiyama, S., Fukumoto, D., Sato, K., Kakiuchi, T., & Domino, E. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300732 · Cited by 93
Melchitzky, D. S., & Lewis, D. A. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.5.452 · Cited by 84
Self-citationWhat can research on schizophrenia tell us about the cognitive neuroscience of working memory?
Barch, D. M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.013 · Cited by 58
Dopamine Transmission in the Schizophrenic Brain
Laruelle, M. A. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch20 · Cited by 53
González‐Burgos, G., Kroener, S., Seamans, J. K., Lewis, D. A., & Barrionuevo, G. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00698.2005 · Cited by 51
Self-citationHuntley, G. W., Vickers, J. C., & Morrison, J. H. (1997) · Brain Research · doi:10.1016/s0006-8993(96)00847-5 · Cited by 47
Toward a Prefrontal Microcircuit Model for Cognitive Deficits in Schizophrenia
Wang, X. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-931501 · Cited by 38
Dopamine modulation of neuronal function in the monkey prefrontal cortex
González‐Burgos, G., KRONER, S., Krimer, L. S., Seamans, J. K., Urban, N. N., Henze, D. A., Lewis, D. A., & Barrionuevo, G. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00940-x · Cited by 37
Self-citationCho, R. Y., Ford, J. M., Krystal, J. H., Laruelle, M. A., Cuthbert, B. C., & Carter, C. S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi050 · Cited by 37
Dudkin, K. N., Kruchinin, V. K., & Chueva, I. V. (2001) · Neuroscience and Behavioral Physiology · doi:10.1023/a:1005224610354 · Cited by 15
Cited by
Neurophysiological and Computational Principles of Cortical Rhythms in Cognition
Wang, X.-J. (2010) · Physiological Reviews · doi:10.1152/physrev.00035.2008 · Cited by 1,939
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring
Stephan, K. E., Friston, K. J., & Frith, C. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn176 · Cited by 1,134
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Optogenetic investigation of neural circuits underlying brain disease in animal models
Tye, K. M., & Deisseroth, K. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3171 · Cited by 745
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Metadata
- Authors
- Lewis, D. A., & Gonzalez-Burgos, G.
- Venue
- Nature Medicine
- Published
- 2006-09
- Volume
- 12
- Issue
- 9
- Pages
- 1016-1022
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2009928774
- Cited by
- 323
- References
- 106
- FWCI
- 17.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.